Atlas Trials

Transition cAre inteRvention tarGeted to High-risk patiEnts To Reduce rEADmission

Clinical trial NCT03496896 · COMPLETED

Trial details

NCT number
NCT03496896
Sponsor
Insel Gruppe AG, University Hospital Bern
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Patient Readmission
Start date
2018-04-03
Primary completion
2020-02-15
Enrollment
1393

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.